{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:20:05Z","timestamp":1793751605881,"version":"4.6.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neubiorev.2025.106108","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:32:58Z","timestamp":1742052778000},"page":"106108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy of opioid antagonist in patients with binge eating behavior: A systemic review and meta-analysis"],"prefix":"10.1016","volume":"172","author":[{"given":"Yi-Ya","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu","family":"Tien-Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ajcn\/53.4.865","article-title":"Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects","volume":"53","author":"Alger","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neubiorev.2025.106108_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (Vol. 4)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.neubiorev.2025.106108_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (Vol. 5)","author":"American Psychiatric Association","year":"2013"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106108_bib4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4088\/JCP.v63n1113","article-title":"A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder","volume":"63","author":"Arnold","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106108_bib5","unstructured":"Beck, A.T., Steer, R.A., & Brown, G. (2009). Inventario de depresi\u00f3n de Beck: BDI-II: manual. Paid\u00f3s."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","article-title":"Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder","volume":"17","author":"Bello","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neubiorev.2025.106108_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss","volume":"84","author":"Billes","year":"2014","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106108_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1017\/S1092852920001674","article-title":"General impulsivity in binge-eating disorder","volume":"26","author":"Boswell","year":"2021","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib9","first-page":"88","article-title":"Gastrointestinal symptoms in bulimia nervosa: effects of treatment","volume":"90","author":"Chami","year":"1995","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1037\/0003-066X.62.3.159","article-title":"Eating disorders: National Institute of Mental Health's perspective","volume":"62","author":"Chavez","year":"2007","journal-title":"Am. Psychol."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106108_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4088\/JCP.v68n0901","article-title":"Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder","volume":"68","author":"Claudino","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0031-9384(02)00690-X","article-title":"Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats","volume":"76","author":"Echo","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neubiorev.2025.106108_bib13","unstructured":"Fairburn, C.G. (2008). Cognitive behavior therapy and eating disorders. Guilford Press."},{"issue":"1 Pt 2","key":"10.1016\/j.neubiorev.2025.106108_bib14","first-page":"R217","article-title":"Potency of naloxone's anorectic effect in rats is dependent on diet preference","volume":"271","author":"Glass","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4603(82)90024-7","article-title":"The assessment of binge eating severity among obese persons","volume":"7","author":"Gormally","year":"1982","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.11.002","article-title":"Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinthera.2020.10.010","article-title":"Naltrexone +\u2009Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study","volume":"43","author":"Grilo","year":"2021","journal-title":"Clin. Ther."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106108_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","article-title":"Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial","volume":"179","author":"Grilo","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106108_bib19","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/oby.23898","article-title":"Naltrexone\/bupropion for binge-eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Grilo","year":"2023","journal-title":"Obes. (Silver Spring)"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106108_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/hup.2547","article-title":"Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial","volume":"31","author":"Guerdjikova","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.mcna.2019.02.003","article-title":"Update on binge eating disorder","volume":"103","author":"Guerdjikova","year":"2019","journal-title":"Med Clin. North Am."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106108_bib23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4088\/JCP.v64n1208","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures","volume":"64","author":"Hedges","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106108_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40263-017-0477-1","article-title":"Lisdexamfetamine: a review in binge eating disorder","volume":"31","author":"Heo","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2025.106108_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114267","article-title":"Psychological and medical treatments for binge-eating disorder: a research update","volume":"269","author":"Hilbert","year":"2023","journal-title":"Physiol. Behav."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106108_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1517\/13543784.2011.592139","article-title":"Opioid modulators for alcohol dependence","volume":"20","author":"Hillemacher","year":"2011","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.neubiorev.2025.106108_bib27","first-page":"1","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders","author":"Himmerich","year":"2023","journal-title":"World J. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106108_bib28","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patientswith type 2 diabetes","volume":"36","author":"Hollander","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106108_bib29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106108_bib30","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3945\/ajcn.2010.29203","article-title":"Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder","volume":"91","author":"Hudson","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106108_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","article-title":"Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"74","author":"Hudson","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106108_bib32","unstructured":"Huecker, M.R., Smiley, A., & Saadabadi, A. (2024). Bupropion. In StatPearls [Internet]. StatPearls Publishing."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106108_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-1781(88)90062-5","article-title":"The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone","volume":"24","author":"Jonas","year":"1988","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106108_bib34","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.22-09-03306.2002","article-title":"The neuroscience of natural rewards: relevance to addictive drugs","volume":"22","author":"Kelley","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106108_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","article-title":"The neurobiological basis of binge-eating disorder","volume":"63","author":"Kessler","year":"2016","journal-title":"Neurosci. Biobehav Rev."},{"issue":"22","key":"10.1016\/j.neubiorev.2025.106108_bib36","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12888-024-05943-5","article-title":"Comorbidity of binge eating disorder and other psychiatric disorders: a systematic review","volume":"24","author":"Kowalewska","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106108_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/21677026221144255","article-title":"The link between low self-esteem and eating disorders: a meta-analysis of longitudinal studies","volume":"11","author":"Krauss","year":"2023","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106108_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2147\/NDT.S168944","article-title":"Binge eating in patients with polycystic ovary syndrome: prevalence, causes, and management strategies","volume":"15","author":"Krug","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.fertnstert.2016.12.014","article-title":"Increased risk of disordered eating in polycystic ovary syndrome","volume":"107","author":"Lee","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neubiorev.2025.106108_bib41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40519-018-0533-y","article-title":"Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Lee","year":"2019","journal-title":"Eat. Weight Disord. -Stud. Anorex., Bulim. Obes."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106108_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.18773\/austprescr.2015.063","article-title":"Naltrexone and liver disease","volume":"38","author":"McDonough","year":"2015","journal-title":"Aust. Prescr."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106108_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/eat.22114","article-title":"A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder","volume":"46","author":"McElroy","year":"2013","journal-title":"Int J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/eat.22452","article-title":"Medical comorbidity and medical complications associated with binge-eating disorder","volume":"49","author":"Mitchell","year":"2016","journal-title":"Int J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106108_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-198904000-00004","article-title":"A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia","volume":"9","author":"Mitchell","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106108_bib48","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/npp.2016.269","article-title":"Pathological overeating: emerging evidence for a compulsivity construct","volume":"42","author":"Moore","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106108_bib49","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S146114570900039X","article-title":"From taste hedonics to motivational drive: central \u03bc-opioid receptors and binge-eating behaviour","volume":"12","author":"Nathan","year":"2009","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib50","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0091270011399577","article-title":"Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel \u03bc-opioid receptor inverse agonist","volume":"52","author":"Nathan","year":"2012","journal-title":"J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"Int J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106108_bib52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000338163","article-title":"The opioid system and food intake: homeostatic and hedonic mechanisms","volume":"5","author":"Nogueiras","year":"2012","journal-title":"Obes. Facts"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0272-7358(02)00201-5","article-title":"Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships","volume":"23","author":"O'Brien","year":"2003","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40519-016-0313-5","article-title":"Medical comorbidity of binge eating disorder","volume":"22","author":"Olguin","year":"2017","journal-title":"Eat. Weight Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106108_bib55","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1530-0277.2007.00347.x","article-title":"Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial","volume":"31","author":"O'Malley","year":"2007","journal-title":"Alcohol Clin. Exp. Res"},{"key":"10.1016\/j.neubiorev.2025.106108_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J. Surg."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1556\/2006.5.2016.018","article-title":"Life adverse experiences in relation with obesity and binge eating disorder: a systematic review","volume":"5","author":"Palmisano","year":"2016","journal-title":"J. Behav. Addict."},{"issue":"50","key":"10.1016\/j.neubiorev.2025.106108_bib58","doi-asserted-by":"crossref","first-page":"11777","DOI":"10.1523\/JNEUROSCI.2329-05.2005","article-title":"Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?","volume":"25","author":"Peci\u00f1a","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2010.05.016","article-title":"Hedonic and motivational roles of opioids in food reward: implications for overeating disorders","volume":"97","author":"Peci\u00f1a","year":"2010","journal-title":"Pharm. Biochem Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comppsych.2009.03.003","article-title":"Personality dimensions in bulimia nervosa, binge eating disorder, and obesity","volume":"51","author":"Peterson","year":"2010","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106108_bib61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/14656566.2016.1145660","article-title":"Opioid antagonists in broadly defined behavioral addictions: a narrative review","volume":"17","author":"Piquet-Pess\u00f4a","year":"2016","journal-title":"Expert Opin. Pharm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40337-023-00751-w","article-title":"Renal and electrolyte complications in eating disorders: a comprehensive review","volume":"11","author":"Puckett","year":"2023","journal-title":"J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mehy.2010.09.002","article-title":"Hypothalamic opioid\u2013Melanocortin appetitive balance and addictive craving","volume":"76","author":"Reece","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40337-023-00833-9","article-title":"Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review","volume":"11","author":"Rodan","year":"2023","journal-title":"J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib65","first-page":"164","article-title":"Naltrexone\/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults","volume":"41","author":"Sherman","year":"2016","journal-title":"P t"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106108_bib66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuroscience.2010.07.017","article-title":"Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens","volume":"170","author":"Shin","year":"2010","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106108_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3758\/s13415-019-00710-6","article-title":"The role of the opioid system in decision making and cognitive control: A review","volume":"19","author":"van Steenbergen","year":"2019","journal-title":"Cogn. Affect Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106108_bib68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/nu16071049","article-title":"Food cravings and obesity in women with polycystic ovary syndrome: pathophysiological and therapeutic considerations","volume":"16","author":"Stefanaki","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106108_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamapsychiatry.2019.2914","article-title":"Association of bulimia nervosa with long-term risk of cardiovascular disease and mortality among women","volume":"77","author":"Tith","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"34","key":"10.1016\/j.neubiorev.2025.106108_bib70","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1523\/JNEUROSCI.0976-17.2017","article-title":"Feeding releases endogenous opioids in humans","volume":"37","author":"Tuulari","year":"2017","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106108_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14740\/jocmr4066","article-title":"The opioid system and food intake: use of opiate antagonists in treatment of binge eating disorder and abnormal eating behavior","volume":"12","author":"Valbrun","year":"2020","journal-title":"J. Clin. Med Res"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106108_bib72","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1523\/JNEUROSCI.23-07-02882.2003","article-title":"Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network","volume":"23","author":"Will","year":"2003","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106108_bib73","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/eat.20728","article-title":"Validity and utility of the current definition of binge eating","volume":"42","author":"Wolfe","year":"2009","journal-title":"Int. J. Eat. Disord."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106108_bib74","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mp.2012.154","article-title":"Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects","volume":"18","author":"Ziauddeen","year":"2013","journal-title":"Mol. Psychiatry"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:30:44Z","timestamp":1777642244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":74,"alternative-id":["S0149763425001083"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106108","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of opioid antagonist in patients with binge eating behavior: A systemic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106108"}}